NCT00015704 - Effect of Interleukin-2 on HIV Treatment Interruption | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

November 30, 2004

Conditions

HIV Infections

Interventions

DRUG

Aldesleukin

Trial Locations (17)

Beth Israel Med. Ctr., ACTU, New York

Cornell CRS, New York

Pitt CRS, Pittsburgh

Duke Univ. Med. Ctr. Adult CRS, Durham

Case CRS, Cleveland

University of Minnesota, ACTU, Minneapolis

Rush Univ. Med. Ctr. ACTG CRS, Chicago

Washington U CRS, St Louis

MetroHealth CRS, Cleveland

Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr., Omaha

Stanford CRS, Palo Alto

San Mateo County AIDS Program, San Mateo

UCLA CARE Center CRS, Los Angeles

Santa Clara Valley Med. Ctr., San Jose

St. Louis ConnectCare, Infectious Diseases Clinic, St Louis

Weill Med. College of Cornell Univ., The Cornell CTU, New York

Unc Aids Crs, Chapel Hill

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH